Evidence-Based Myopia Management – Clinical Implications of the New Standard of Care

September 21, 2021

Evidence-Based Myopia Management – Clinical Implications of the New Standard of Care

September 21, 2021

Myopia is thought to be a modifiable risk factor for the development of eye disease and vision loss.

As a result, alleviating Myopia symptoms with spectacles or contact lenses is no longer considered sufficient. The World Council of Optometry, the European Society of Ophthalmology, and the International Myopia Institute have recently called for an evolution in the standard of care for Myopia management

James Loughman is the Clinical Research Director for Ocuco Ltd.

An Optometrist with more than 20 years of clinical, academic, research and management experience, James recently joined Ocuco as Clinical Research Director. James is also presently the Director of the Centre for Eye Research Ireland, a research facility based in the Dublin Institute of Technology, the same university where he received his PhD in 1997; James oversees a portfolio of research including technology development and big data analytics projects alongside various clinical trials for the control of myopia, glaucoma and other blinding conditions.

25 Sep 2024

Beyond Compliance: The Comprehensive Benefits of Good Record Keeping

Following the success of a previous webinar on the regulatory intricacies of record-keeping, a continuation…

21 May 2020

Myopia and Vision Loss: Can Electronic Medical Records (EMR) Help to Quantify the Problem?

This webinar explores electronic medical records (EMR) as an alternative source of epidemiological data and…

23 May 2024

Record Keeping

This insightful webinar highlights the importance of good record-keeping in optical practice delivered by Peter…

Notice of Data Breach : Learn about a data breach Ocuco recently experienced